Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

National Health Surveillance Agency ANVISA Authorizes Doctor s Prescription for RSHO™ to Treat Patient Suffering from Effects of Alzheimer s Disease PR Newswire, MJNA SAN DIEGO, Feb. 7, 2017 SAN DIEGO, Feb. 7, 2017 /PRNewswire/  Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor s prescription for the Company s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in
http://bit.ly/2llytJl